Alnylam Competitors and Similar CompaniesClear all
Sorrento Therapeutics's competitors and similar companies include Regulus Therapeutics.
 Sorrento Therapeutics Sorrento Therapeutics is focused on the development of proprietary drug therapeutics for addressing unmet medical needs.
|  Regulus Therapeutics Regulus Therapeutics is a biopharmaceutical company involved in the R&D of high-impact medicines based on microRNAs. | |
Founding Date | Founding Date 2006 | Founding Date 2007 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations San Diego, US HQ San Diego, US | Locations San Diego, US HQ |
Employees | Employees 31019% decrease | Employees 2462% decrease |
Valuation ($) | Valuation ($) 1.5 m | Valuation ($) 105.4 m |
Financial | ||
Net income | Net income ($577.8m) (FY, 2022) | Net income ($30m) (FY, 2023) |
Funding | ||
Total funding raised | Total funding raised $ 42.6m | Total funding raised $ 10m |
For sources of this data, please see the company profile
View Company Profiles
Regulus Therapeutics
HQ
San Diego, US
Employees
24
Regulus Therapeutics is a biopharmaceutical company involved in the R&D of high-impact medicines based on microRNAs.
View company